Similar articles

• [Drugs inhibiting the function of oncogene products, especially protein tyrosine kinases].

  Akiyama T, Ogawara H. Akiyama T, et al. Seikagaku. 1987 Sep;59(9):1016-20. Seikagaku. 1987. PMID: 3437165 Japanese. No abstract available.
• [Inhibitors for protein tyrosine kinases, erbstatin, genistein and herbimycin A, induce differentiation of human neural tumor cell lines].

  Matsumoto M. Matsumoto M. Nihon Geka Hokan. 1991 Mar 1;60(2):113-21. Nihon Geka Hokan. 1991. PMID: 1668058 Japanese.
• Protein tyrosine kinase inhibitors promote amylase secretion and inhibit ornithine decarboxylase induction in sialagogue-stimulated rat parotid explants.

  Kinoshita F, Ueno A, Miwa Y, Nishino M, Inoue H. Kinoshita F, et al. Biochem Biophys Res Commun. 1996 Jun 5;223(1):170-4. doi: 10.1006/bbrc.1996.0864. Biochem Biophys Res Commun. 1996. PMID: 8660365
• Inhibition of protein tyrosine phosphorylation in endothelial cells: relationship to antiproliferative action of genistein.

  Koroma BM, de Juan E Jr. Koroma BM, et al. Biochem Soc Trans. 1997 Feb;25(1):35-40. doi: 10.1042/bst0250035. Biochem Soc Trans. 1997. PMID: 9056839 Review. No abstract available.
• [Biological activity of oncogene function inhibitors isolated from microorganisms].

  Umezawa K. Umezawa K. Seikagaku. 1992 Mar;64(3):160-71. Seikagaku. 1992. PMID: 1535644 Review. Japanese. No abstract available.